multiple sclerosis
-
A study finds Canada ranks last for women’s representation among senior authors in Nature Physics, with zero female-led Canadian papers in the past decade.
-
Depression, anxiety may be among early signs of MS
New research is painting a clearer picture of the early signs of multiple sclerosis (MS), showing that people are nearly twice as likely to experience mental illness in the years leading up to the onset of the diseases.
-
$33.8M gift to transform MS research and save more lives, sooner
A $33.8 million gift has been donated to the University of British Columbia and VGH & UBC Hospital Foundation for multiple sclerosis (MS) research and care—the largest known donation ever for MS research worldwide.
-
Living near major roads linked to increased risk of dementia, Parkinson’s, Alzheimer’s and MS
Living near major roads or highways is linked to higher incidence of dementia, Parkinson’s disease, Alzheimer’s disease and multiple sclerosis (MS), suggests new research published this week in the journal Environmental Health.
-
Scientists edge closer to root causes of multiple sclerosis
An international team of researchers led by the University of British Columbia has made a scientific advance they hope will lead to the development of preventative treatments for multiple sclerosis (MS).
-
Common treatment for multiple sclerosis may prolong life
Researchers from the University of British Columbia and Vancouver Coastal Health Research Institute have found that a widely prescribed drug for multiple sclerosis (MS) is associated with longer survival for patients.
-
Disability progression in multiple sclerosis linked to income, education
Neighbourhood income and education level is associated with risk of disability progression in patients with multiple sclerosis, suggests new research from the University of British Columbia.
-
UBC researchers discover how blood vessels protect the brain during inflammation
Researchers from the University of British Columbia have discovered how blood vessels protect the brain during inflammation—a finding that could lead to the development of new treatments for neurodegenerative diseases such as stroke, epilepsy and multiple sclerosis.
